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Colorectal cancer is the second leading cause of 
cancer related-death and the third most commonly 
diagnosed cancer in the United �tates�� with approxi-
mately �������� new cases diagnosed per year [��� �]. 
If detected very early in the course of the disease�� 
surgical resection may �e adequate�� �ut many patients 
still need supplemental chemotherapy or radiotherapy. 
In most cases�� commonly used chemotherapies 
are limited �y severe side effects and dose-limiting 
toxicity. Adding more drugs or increasing the dos-
ages increases the pro�a�ility of adverse effects. The 
drug-related adverse events not only worsen patients’ 
quality of life�� �ut can also lead to their refusal to 
continue the potentially curative chemotherapy [3]. 
Newer therapies involving targeted chemotherapy of 
metastatic colorectal cancer are also associated with 
undesira�le adverse effects [4]. Considering these 
facts�� significant improvement in treating patients with 
colorectal cancer is required. 
In the last two decades�� �otanicals with effective 
anti-cancer activity have �een researched. The use of 
her�al medicines is also on the rise in cancer patients 
[��� 6]. Long-term consumption of certain �otanicals 
could �e associated with reduced cancer incidence 
and thus has an epidemiological �asis for further 
investigation. Research that explores new �otanical 
candidates with potential anti-cancer effects is im-
perative�� and allows for the development of safe and 
efficacious anti-cancer therapies [��� �].
Crocus sativus is a plant of the iris family �Iridaceae�� 
and its flower contains various chemical constituents 
[�]. �tigmas of the flower �saffron�� contain crocin�� 
anthocyanin�� carotene and lycopene [��]�� and these 
constituents have various pharmacological effects on 
different illness�� including anti-tumor effects �y inhi�i-
tion of cell growth [��].  Recently�� Crocus sativus extract 
�C�E�� was found to have anti-cancer activities against 
leukaemia�� osteosarcoma�� fi�rosarcoma and ovarian 
carcinoma cells [�]. Crocin �Fig. ��� is a main constitu-
ent of the C�E. However�� effects of C�E and crocin on 
human colorectal cancer have not �een evaluated. 
In this study�� using high performance liquid chro-
matography �HPLC���� we analyzed C�E and its content 
of crocin. The anti-proliferation effects of C�E and 
crocin were evaluated in three human colorectal can-
cer cell lines�� i. e.�� HT-���� �W-4�� and HCT-��6. The 
inhi�itory effects on colorectal cancer cell growth were 
also compared to a different cancer�� non-small cell 
lung cancer �N�CLC�� cells. Additionally�� we also tested 
if C�E’s anti-proliferative effects can �ee seen in non-
cancer young adult mouse colon �YAMC�� cells. 
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Fig. 1. Chemical structure of crocin �MW: ����� 
MATERIALS AND METHODS
Plant extract, HPLC analysis, and chemicals. 
C�E and crocin were o�tained from Prof. Y. �hoyama’s 
la�oratory in the Faculty of Pharmaceutical �ciences�� 
Kyushu University�� Japan. 
For HPLC analysis�� we used Waters �6�� liquid chro-
matographic system equipped with a ��6 photo diode ar-
ray detector �Milford�� MA��. The separations were carried 
out on a Phenomenex Prodigy OD����� C�� column ���� 
× 3.� mm�� � µm�� �Torrance�� CA��. The precolumn was a 
Phenomenex C�� column �3� × 3.� mm��. The diode array 
detector was set to an acquisition range of ������� nm 
at a spectral acquisition rate of �.�� scans/s. 
For the mo�ile phase�� we used solvent A �methanol�� 
and solvent B ��% [v/v] aqueous acetic acid in water��. 
The mixing of the gradient solvent eluting system 
was as follows: initial 3�% A and ��% B; ��� min�� 
linear change to 4�% A; ���� min�� change to ��% A; 
����� min�� change to 6�% A; ����� min�� change to 
��% A; ���3� min�� ��% A; 3��33 change to 3�% A; 
33�4�min�� 3�% A. The flow rate of the mo�ile phase 
was �.� ml/min and the injection volume was �� µl. The 
detection wavelength was set to 44� nm. All solutions 
were filtered through a �.� µm hydrophilic polypropyl-
ene mem�rane �Pall Gelman La�oratory�� Ann Ar�or�� 
MI�� �efore use. �eparation was accomplished at the 
temperature of �� °C. 
Five different concentrations of crocin solutions were 
prepared for the determination of the cali�ration curve. 
The cali�ration curve was constructed with crocin con-
tent versus peak area �y = �46�.3 + �663��� R� = �.������ 
linear range: �.�����.� mg/ml��. The content of crocin in 
C�E was calculated using the standard curve of crocin.
All solvents were of HPLC grade from Fisher �cien-
tific �Norcross�� GA��. Trypsin�� McCoy’s �A�� Lei�ovitz’s 
L-���� RPMI �64� medium�� fetal �ovine serum �FB����� 
and penicillin/streptomycin solution ����×�� were o�-
tained from Mediatec �Herndon�� VA��. A CellTiter �6 
Aqueous One �olution Cell Proliferation Assay kit was 
o�tained from Promega �Madison�� WI��. 
Cell culture. Human colorectal cancer cells HCT-��6 
�McCoy’s �A���� HT-�� �McCoy’s �A�� and �W-4�� �Lei-
�ovitz’s L-������ and human non-small cell lung cancer 
�N�CLC�� cells �RPMI �64��� were o�tained from American 
Type Culture Collection �Manassas�� VA��. Non-cancer 
young adult mouse colon �YAMC�� cells �RPMI �64��� were 
o�tained from Prof. E.B. Chang in the Digestive Diseases 
Research Core Center at the University of Chicago. For 
cancer cell culture�� indicated medium containing ��% fe-
tal �ovine serum and penicillin/streptomycin was placed 
in a humidified atmosphere with �% CO� at 3� °C. For 
YAMC cell culture�� a humidified atmosphere was main-
tained with �% CO� at 33 °C. Medium was changed every 
��3 days. When the cells reached �����% confluence�� 
they were trypsinized�� harvested�� and seeded into a new 
tissue culture flask [����4].
Anti-proliferation assay using MTS method. 
Cells were seeded in �6-well plates �� x ��4 cells/well��. 
After �4 h�� the medium was changed and various con-
centrations of C�E or crocin were added to the wells. 
All experiments were performed at least in triplicate. 
After 4� h of treatment�� cell growth was evaluated 
using a modified trichrome stain �MT��� assay accord-
ing to the manufacturer’s requirement. Briefly�� at the 
end of incu�ation period�� the medium was replaced 
with ��� µl of fresh medium�� �� µl of MT� reagent in 
each well�� and the plate was placed in an incu�ator 
for ��� h. A 6� µl aliquot of medium from each well 
was transferred to an ELI�A �6-well plate and its 
a�sor�ance at 4�� nm was recorded [��]. Our previ-
ous data showed that results o�tained from the MT� 
method are compara�le to that o�tained from the cell 
counting method [�6]. 
Statistical analysis. Data are presented as 
mean ± standard error ��E��. Data were analyzed using 
�tudent’s t-test and analysis of variance �ANOVA�� for 
repeated measures. The level of statistical significance 
was set at P < �.��.
RESULTS
HPLC analysis of crocin and C�E. Chromatogram of 
crocin is shown in Fig. ��� a. Ta�le � indicates retention 
times and peak areas for the crocin and three impuri-
ties. Crocin has maximum a�sorption near 44� nm and 
we select 44� nm as the assay wavelength. The purity 
of crocin is ��.�%.
Table 1. Purity analysis of crocin
Crocin Impurity 1 Impurity 2 Impurity 3
Retention time (min) 10.70 11.17 18.92 21.82
Peak area 2.094 x 107 8.042 x 105 6.303 x 104 3.742 x 104
Percent (%) 95.9 3.7 0.3 0.2
Fig. �B shows the chromatogram of the C�E. The 
ultraviolet-visi�le �UV-Vis�� spectrum of the crocin peak 
is also shown. From the chromatogram�� crocin was 
the major compound in the C�E�� and it was clearly 
separated from other components. Determinations 
were repeated three times and the results are shown 
in Ta�le ��� in which the content of crocin in the C�E 
is ��.�%. The C�E at a concentration of 3.� mg/ml 
contained approximately �.6 mM crocin.
Table 2. Determination of crocin in Crocus sativus extract
Assay Peak Area Content (%) Average Content (%) SD RSD
1 1.261 x 107 22.91
22.9 0.1 0.5%2 1.256 x 107 22.82
3 1.268 x 107 23.03
Effects of C�E and crocin on proliferation of 
colorectal cancer cell lines. Fig. 3�� a shows the con-
centration-related effects of C�E on the three cancer 
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cell lines. C�E has significant anti-proliferative effects 
on all three tested cell lines�� HCT-��6�� �W-4�� and 
HT-�� �P < �.����. The proliferation was reduced most 
significantly in HCT-��6 cells�� 4�.�% proliferation at a 
concentration of �.� mg/ml and 6.�% at a concentra-
tion of 3 mg/ml. Although �W-4�� and HT-�� cells 
responded to the extract well�� the effects were not 
as dramatic as that in HCT-��6 cells. �W-4�� cells 
showed that proliferation reduced to ��.�% and ��.6% 
at �.� mg/ml and 3.� mg/ml�� respectively. HT-�� cells 
showed that the proliferation reduced to ��.�% and 
��.�% at �.� mg/ml and 3.� mg/ml�� respectively.
Crocin is a major component in the C�E. Fig. 3�� b 
shows the relationship �etween crocin concentration 
and the inhi�ition of proliferation of the three cell lines. 
At �.� mM concentration�� HCT-��6�� �W-4�� and HT-�� 
cells proliferation was significantly reduced to �.��� 
�� and �6.�% proliferation�� respectively �P < �.����. 
Consistent with the C�E data�� crocin has the most 
significant anti-proliferative effect on HCT-��6 cells.
Effects of C�E and crocin on proliferation of N�CLC 
cells. In addition to colorectal cancer cells�� we also 
evaluated the effects of C�E and crocin on non-diges-
tive system cancer cells�� i.e.�� non-small cell lung cancer 
�N�CLC�� cells. Our data showed that at �.� mg/ml and 
3.� mg/ml�� C�E reduced the N�CLC proliferation to 
�3.�% �P < �.���� and 34.�% �P < �.������ respectively 
�Fig. 4�� a��. At �.� mM crocin concentration�� the cell pro-
liferation was reduced to 43.3% �P < �.��; Fig. 4�� b��.
Fig. 3. Effects of Crocus sativus extract and crocin on prolifera-
tion of three human colorectal cancer cells. Cancer cells were 
exposed to Crocus sativus extract or C�E �a�� and crocin �b�� for 
4� h and cell proliferation was determined �y MT� method. C�E 
and crocin have the most potent anti-proliferative activities on 
HCT-��6 cells. Control at 4� h is normalized to ���%
Fig. 2. HPLC chromatograms of crocin �a�� and Crocus sativus extract �b��. HPLC condition is descri�ed in Material and Methods section. 
UV-Vis or ultraviolet-visi�le spectrum of crocin �������� nm�� was shown in the right side of the figure.  Num�er “�” indicates the peak of crocin 
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Fig. 4.  Effects of Crocus sativus extract and crocin on prolifera-
tion of non-small cell lung cancer �N�CLC�� cells. Cancer cells 
were exposed to Crocus sativus extract or C�E �a�� and crocin �b�� 
for 4� h and cell proliferation was determined �y MT� method. 
Control at 4� h is normalized to ���%
C�E does not affect proliferation of non-cancer 
YAMC cells. In this part of the study�� the effect of C�E 
on non-cancer young adult mouse colon �YAMC�� cells 
was compared to that of the HCT-��6 cells. As shown 
in Fig. ��� at the tested concentration range�� C�E did 
not show any significant inhi�ition of the YAMC cells�� 
while cell growth was significantly inhi�ited in HCT-��6 
cells at �.� mg/ml �P < �.����. 
Fig. 5. Effects of Crocus sativus extract on proliferation of non-
cancer young adult mouse colon �YAMC�� cells and colorectal 
cancer HCT-��6 cells.  The two different cells were exposed to 
Crocus sativus extract �C�E�� for 4� h and cell proliferation was 
determined �y MT�. Only HCT-��6 cell growth was significantly 
inhi�ited at �.� mg/ml C�E
*P < �.�� vs. control. Control at 4� h is normalized to ���%.
DISCUSSION
Crocus sativus L. �elongs to Iridaceae family�� and 
is cultivated in Asian�� Europe and America [��]. �af-
ranal in Crocus sativus is the volatile oil responsi�le 
for odor and aroma. Crocus sativus has �een used 
to treat several medical conditions�� such as gastro-
intestinal disorders�� urological infections�� as well as 
in treating malignancies [��� ���� ��]. C�E used in this 
study was prepared from stigmas of Crocus sativus. 
C�E contains several pharmacologically active con-
stituents. �affron-colored compounds are unusual 
water-solu�le carotenoids which contain mono and 
diglycosyl esters of a polyene dicar�oxylic acid. The 
digentio�iosyl ester compound�� i. e.�� alpha crocin�� or 
crocin�� is the major component of C�E. Additionally�� 
C�E also contains amino acids�� flavonoids�� and other 
chemical compounds [���� ��]. Among these com-
pounds�� crocin is the most important since it is the 
major compound in C�E and has shown significant 
�iological activities [��].  
�tandardization of active constituents�� such as cro-
cin from C�E�� is a critical issue for research and potential 
commercialization of �otanicals. Quantitative HPLC can 
quickly assay C�E from different sources and its results 
help to determine which sample�s�� should �e selected 
[��]. In this study�� we developed an HPLC method and 
the extract used in our study was analyzed. Thus�� the 
measured C�E and crocin can �e a reference for future 
investigations. Our data showed compara�le anti-pro-
liferative effects of 3.� mg/ml C�E vs. �.� mM crocin. 
�ince 3.� mg/ml C�E contained approximately �.6 mM 
crocin�� the o�served effects suggested that crocin is a 
major responsi�le constituent in the C�E.
We demonstrated significant anti-proliferative ef-
fects of C�E and crocin on three different colorectal 
cancer cell lines. Each of these cell lines originated from 
a unique patient tumor �iopsy�� and has �een extensively 
studied [���� �3]. These cells are immortal�� and therefore 
offer a renewa�le and endless supply of consistent 
source material for our investigation. We studied three 
cell lines to acknowledge and represent the genetic 
heterogeneity�� and consequent varia�le responsive-
ness to treatment regimens found in colorectal cancer 
patients. Importantly�� our data also demonstrated that 
at concentrations with the inhi�ition of colon cancer cell 
growth�� the extract did not affect non-cancer cells�� such 
as young adult mouse colon cells.
Comparing our data of three studied colorectal 
cancer cell lines�� HCT-��6 showed significant higher 
sensitivity to C�E and crocin than other two cells�� 
�W-4�� and HT-��. In cancer chemotherapy�� induc-
tion of cancer cell apoptosis has �een emphasized�� 
and the cell apoptosis is mediated �y many factors. 
Among them�� P�3 is a transcription factor placed at the 
nexus of a num�er of pathways that mediate apoptosis 
in response to a wide range of cellular stresses [�4]. 
HCT-��6 cells are p53 wild-type�� while �W-4�� and 
HT-�� cells are mutant in the p53 tumor suppressor 
gene. �ince the effects of C�E and crocin on HCT-��6 
are stronger than that of HT-�� and �W4���� it suggests 
that some activity of p53 may �e linked to the C�E and 
crocin to express the anti-cancer effects [��].
For comparison purposes�� we also evaluated if 
C�E and crocin could inhi�it other cancer cell growth. 
�ince lung cancer is a very common cancer and ap-
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proximately ��% of all lung cancers are of non-small 
cell type [�6�� ��]�� we selected to test the non-small 
cell lung cancer cells �N�CLC�� cells. �ignificant growth 
inhi�ition of N�CLC cells was o�served after C�E and 
crocin treatments�� suggesting the efficacy of Crocus 
sativus goes �eyond colorectal cancer. 
Crocin from C�E has anti-tumor effects on cellular 
DNA and RNA synthesis [���� ��].  Another mechanism 
for the anti-tumor action of C�E and its constituents 
is the inhi�itory effect on free radical chain reactions 
[��]�� �ecause most carotenoids are lipid-solu�le and 
might act as mem�rane-associated high-efficiency 
free radical scavengers�� connects with their anti-oxi-
dant properties [3��� 3�]. 
In summary�� data from this study suggest that 
crocin from C�E may �e efficacious in treating certain 
colorectal cancer. Considering the popularity of �o-
tanical use in cancer patients�� Crocus sativus should 
�e investigated further as a via�le option in the treat-
ment of colorectal cancer. 
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КРОЦИН, ПОЛУЧЕННЫЙ ИЗ CROCUS SATIVUS, ОБЛАДАЕТ 
ВЫРАЖЕННЫМ АНТИПРОЛИФЕРАТИВНЫМ ДЕЙСТВИЕМ ПО 
ОТНОШЕНИЮ К КЛЕТКАМ КОЛОРЕКТАЛЬНОГО РАКА ЧЕЛОВЕКА
Цель: исследовать антипролиферативный эффект экстракта Crocus sativus и его главного действующего вещества, кроцина, 
на три клеточные линии колоректального рака человека (HCT-116, SW-480 и HT-29). Эффект ингибирования роста 
клеток оценивали по отношению к таковому для клеток немелкоклеточного рака легкого (НМРЛ) и немалигнизированных 
клеток. Методы: для очистки кроцина и составляющих экстракта C. sativus применяли высокоэффективную жидкостную 
хроматографию (ВЭЖХ). Антипролиферативный эффект экстракта и кроцина по отношению к клеткам оценивали при 
помощи MTS-теста. Результаты: степень очистки кроцина составляла 95,9%, а содержание кроцина в экстракте –22,9%. 
Отмечали существенное дозозависимое угнетение пролиферации клеток трех линий экстрактом C. sativus (P < 0.01). Наиболее 
выраженное снижение пролиферативной активности оотмечали для клеток HCT-116 (дo 45,5 % при 1,0 мг/мл и до 6,8 % при 
3,0 мг/мл). Кроцин в концентрации 1,0 мM, значительно ингибирует пролиферацию клеток HCT-116, SW-480 и HT-29 (до 2,8, 
52 и 16,8% соответственно, P < 0,01). Поскольку 3,0 мг/мл экстракта C. sativus содержат приблизительно 0,6 мM кроцина, 
отмеченное действие первого подтверждает тот факт, что кроцин — главное действующее начало экстракта. Также показано 
существенное антипролиферативное действие по отношению к клеткам НМРЛ. Однако C. sativus не оказывал выраженного 
действия на рост немалигнизированных клеток толстого кишечника молодых мышей. Выводы: данные представленного 
исследования показывают, что экстракт Crocus sativus и его главный действующий компонент кроцин значительно ингибируют 
рост клеточных линий колоректального рака и в то же время не влияют на рост нормальных клеток. В дальнейшем следует 
изучить возможность применения Crocus sativus для лечения больных колоректальным раком. 
Ключевые слова: кроцин, Crocus sativus, шафран, высокоэффективная жидкостная хроматография, клеточные линии 
колоректального рака человека, антипролиферативный эффект.
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